Drawing for TYLZYPRO

USPTO serial 79314247

TYLZYPRO

Reviewed by CopyMark Law Group

Reg. 6908931Status 700Registered
Filing date
Status date
Registration date
Nov 29, 2022
Examiner
CHUO, EMILY M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TYLZYPRO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 20, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jan 24, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 24, 2023FIMPFINAL DISPOSITION PROCESSED—
Dec 29, 2022GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Nov 29, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 29, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 2, 2022GPNXNOTIFICATION PROCESSED BY IB—
Sep 13, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 13, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 7, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 7, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 24, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 9, 2022CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Aug 9, 2022COCOCORRECTION OF OFFICE MISTAKE—
Jun 15, 2022CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
May 3, 2022FINAFINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Mar 11, 2022CRTPREG. CANCELLED - RESTORED TO PENDENCY—
Mar 9, 2022APETASSIGNED TO PETITION STAFF—
Mar 8, 2022RCIIREQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED—
Feb 10, 2022GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jan 11, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 14, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 16, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 9, 2021DOCKASSIGNED TO EXAMINER—
Jul 10, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 9, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 9, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 9, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 9, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 9, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 6, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 4, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 25, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance